Mark M. Garner is currently the Director of the Translational Research Segment at Agilent Technologies. They received their Ph.D. in Biochemistry from Michigan State University, where they invented the widely used gel-shift or "EMSA" assay for studying protein-DNA interactions. Garner has held various prestigious roles, including American Cancer Society Postdoctoral Fellow and Senior Research Scientist at FMC BioProducts, and has been instrumental in the success of several cutting-edge companies, such as Ciphergen Biosystems and AB SCIEX. Their significant contributions to biochemistry and translational research have been recognized through collaborative works and respected publications.
This person is not in any teams
This person is not in any offices